
    
      1. Primary objective: To assess perception of daily and weekly variability of symptoms in
           stable GOLD C and D COPD patients and their impact on daily life activities

        2. Secondary objectives:

             -  To describe the current treatment practice for the management of GOLD C and D COPD
                in MEA countries and their adherence to the GOLD 2015 guidelines

             -  To compare patients' perception of symptoms variability and their impact on
                activities between Gold categories C and D

             -  To identify demographic, behavioral and clinical factors associated with symptoms
                variability.
    
  